Navigation Links
Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record
Date:3/13/2008

s including priceline.com, MINI Cooper, Epson, Greyhound, LucasArts, Diageo Chateau & Estates, The Ritz-Carlton Club and Residences and Nike.

The agency was most recently recognized with two EFFIE awards for its work for MINI and Converse, as well as two Kelly Awards, including the Grand Prize, for its work for MINI.

Contact:

Toni Lee

For Butler, Shine, Stern & Partners

203-761-1292

tlcomm@optonline.net

Lauren Tierney

Take Care Health Systems

484-351-3212

Lauren.Tierney@takecarehealth.com


'/>"/>
SOURCE Butler, Shine, Stern & Partners; Take Care Health Systems
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Tri-C to Celebrate Health Technologies Center Grand Opening April 4
2. Healthcare Tech and the World: Personalized Technology to Benefit Healthcare Consumers in the Future
3. Bay State Restaurants Still Using Artificial Trans Fat Despite Health Risks
4. Catholic Health Initiatives Makes $10 Million Investment in Calvert Foundations Community Investment Notes
5. More Companies, Workers Adopt Consumer-Directed Health Plans
6. The Healthplace America(TM) Benefit Delivers a Better Option in Healthcare
7. RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety
8. Wheelchair Professionals Selects Authentidates Inscrybe Healthcare Platform to Streamline Mobility Order Processing
9. URAC Announces New Leadership to Mine Health Care Management Data and Develop Measurement Programs
10. Despite Looming Shortage of State and Local Public Health Workers, Americans Confident Governments are Prepared to Deal with Public Health Threats
11. Thomson Healthcare Undertakes Medical Staff Development Project for IASIS Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)... finds more than 350 common sets of genes in patie...thDay News) -- Genetic activity in breast cancer c...s tend to more aggressive when they strike at a yo...younger women do worse than older women," said sen...of the clinical trials program in breast cancer at...
(Date:7/9/2008)...rtnership Integrates In-Store and Online Marketing...r Experience, PITTSBURGH and NEW YORK, July 9 /PR...on, ("GNC"), the largest global specialty retailer... ), the leading source of,health information, toda...increase consumer awareness and understanding of t...
(Date:7/9/2008)...ETHESDA, Md., July 9 /PRNewswire/ -- leViv, Inc. ...exclusively on nutrition and lifestyle programs fo...programs today. The new,programs include 28-days o...per day -- over 110 items in every order), online ...ucational resources, professional advice,news, he...
(Date:7/9/2008)...astfeeding.com adds to its unparalleled content on... Center,: 1400 professional articles on child, hea...s and sleep walking., BOULDER, Colo., July 9 /PRN...source with ,Everything for the New Mom, improves ...with over 1400 doctor-reviewed,professional articl...
Breaking Medicine News(10 mins):Health News:Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 2Health News:Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 3Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 3Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2
...ced which has been found to have less side effects...mmunotherapy vaccines. //Antibodies against the al...nt encounters the allergen or infection these anti...o counteract the allergen which is an antigen. Co...
...n at University of California, San Francisco have ...innovative devices to first remove and then recons...ccess tumors. // Tumors which are present in the b...cult to operate. The neurosurgeon used a new tec...
...igration/Macrophage Inhibitory factor (MIF) which ...ultiple Sclerosis. This new pathway can be used in...in a way progression of Multiple Sclerosis is hind.... Multiple Sclerosis is an autoimmune disease wh...
...t tiagabine, a selective ?-aminobutyric acid (GABA... and next-morning alertness and performance in adu...mnia is characterized by difficulty initiating or ...sleep, which causes clinically significant distres...
Other Medicine News:Health News:Oral Edible vaccine for Allergy Vaccines 2Health News:Macrophage Inhibitory Factor Causes Multiple Sclerosis Progression 2
(Date:7/7/2008)...s scientific evidence supporting accuracy of, it...ajor international co...ly 7 /- Molecular,Biometrics, LLC, a ...el,clinical tools for applications in personalized... function in health and disease, presented data fr...
(Date:7/7/2008)...- Biopure Corporation,(Nasd...sions with the Food,and Drug Administration (FDA) ...r a new clinical trial of Hemopure(R) [hemoglobin ... proposed to study use of Hemopure,in patients suf...efuse,transfusion with blood components. Currently...
(Date:7/6/2008)...f Assay Submitted for FDA Clearance, SAN DIEGO, J...segment,of BD (Becton, Dickinson and Company) (NYS...D GeneOhm(TM) Cdiff molecular assay for the rapid ...nfection (CDI). It is the first CDI,diagnostic tes... one test,procedure. BD has also submitted this as...
(Date:7/3/2008)...Newswire-USNewswire/ -- All newborn infants,should...resent at birth,according to a new recommendation... recommendation and the accompanying summary of ev... Children whose hearing is impaired at birth, duri... with verbal and nonverbal communication and,socia...
Breaking Medicine Technology:Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 1Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 2Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 3Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 4Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 5Ovarian cancer risk not affected by alcohol and smoking but reduced by caffeine 9872 1Ovarian cancer risk not affected by alcohol and smoking but reduced by caffeine 9872 2Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 1Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 2Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 3Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 4Deli Chef Tri Bean Salad Recalled From Some Kroger Stores 9868 1
...Point Therapeutics, Inc.,(NASDAQ: POTP) today repo... at the 2007 Annual Meeting of the American,Associ...os Angeles,California, April 14-18, 2007. The AAC...es on talabostat,s novel mechanism of action., Add...follows: , Presentation Date and Time: Monday, Apr...
... - Ascenta Therapeutics,Inc. announced today that...ing compounds will be featured in three oral,prese...week,s 2007,Annual Meeting of the American Associa... Angeles, California April 14-18, 2007., Ascenta,s...t the,"High Impact Late-Breaking Research 1" sessi...
Other Medicine Technology:Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 2Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 3Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 4Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 5Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 6
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: